Compare MUE & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MUE | INFU |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.6M | 182.4M |
| IPO Year | N/A | N/A |
| Metric | MUE | INFU |
|---|---|---|
| Price | $10.10 | $7.60 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 62.6K | ★ 144.5K |
| Earning Date | 01-01-0001 | 03-03-2026 |
| Dividend Yield | ★ 4.09% | N/A |
| EPS Growth | N/A | ★ 271.43 |
| EPS | N/A | ★ 0.26 |
| Revenue | N/A | ★ $141,054,000.00 |
| Revenue This Year | N/A | $8.82 |
| Revenue Next Year | N/A | $2.90 |
| P/E Ratio | ★ N/A | $29.76 |
| Revenue Growth | N/A | ★ 6.23 |
| 52 Week Low | $8.53 | $4.61 |
| 52 Week High | $10.17 | $11.04 |
| Indicator | MUE | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 48.83 | 35.44 |
| Support Level | $10.10 | $7.92 |
| Resistance Level | $10.20 | $8.47 |
| Average True Range (ATR) | 0.09 | 0.38 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 50.05 | 13.45 |
BlackRock MuniHoldings Quality Fund II Inc is a diversified, closed-end management investment company. The fund's investment objective is to provide shareholders with current income exempt from U.S. federal income taxes. The Trust seeks to achieve its investment objective by investing principally in long-term, investment-grade municipal obligations exempt from U.S. federal income taxes. Under normal market conditions, the Trust invests at least 80% of its assets in municipal obligations with remaining maturities of one year or more at the time of investment.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.